Alkermes sells addiction and schizophrenia medicines.
Alkermes plc (ALKS) is expected to report earnings on Tuesday, October 27, 2026, before the open. Estimated release time 07:05 ET. Consensus EPS estimate is $-0.08.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-05-05 | Mar 2026 qtr | $-0.57 | $-0.40 | — | $392.91M |
| 2026-02-25 | Dec 2025 qtr | $0.43 | $0.34 | — | $384.55M |
| 2025-10-28 | Sep 2025 qtr | $0.37 | $0.50 | — | $394.19M |
| 2025-07-29 | Jun 2025 qtr | $0.41 | $0.53 | — | $390.66M |
| 2025-05-01 | Mar 2025 qtr | $0.25 | $0.29 | +13.9% | $306.51M |
| 2025-02-12 | Dec 2024 qtr | $0.81 | $0.90 | +11.1% | $429.99M |
| 2024-10-24 | Sep 2024 qtr | $0.74 | $0.57 | — | $378.14M |
| 2024-07-24 | Jun 2024 qtr | $0.70 | $0.54 | — | $399.13M |
ALKS has beaten consensus EPS in 2 of its last 2 scored quarters.
See ALKS on the live calendar →